Kiromic Biopharma, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
KRBP on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
7707 Fannin St., Suite 140, Houston, TX

Insiders trading volume in the past year

Kiromic Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Maurizio Chiriva CHIEF EXECUTIVE OFFICER, Director $5.1M Sep 9, 2021
Scott Dahlbeck Chief of Staff $1.84M Aug 11, 2022
Gianluca Rotino CHIEF STRAT & INNOV OFFICER, Director $1.04M Jun 22, 2021
Pietro Bersani Chief Executive Officer, Director $517K +$26.9K +5.49% Aug 23, 2024
Michael Ryan Chief Bioinformatics Research Officer $304K Jul 12, 2021
Daniel Clark Chief Financial Officer $232K Aug 11, 2022
Michael Nagel Director $211K +$3.33K +1.61% Jun 11, 2024
Brian Hungerford Chief Financial Officer $143K +$18.1K +14.5% Aug 19, 2024
Pamela Misajon Director $121K +$10.3K +9.27% Jun 12, 2024
Ignacio Nunez Chief Operat. And Manuf. Offi. $65.5K Jun 22, 2021
Michael Catlin Director $27.7K Mar 18, 2024
Jerry Schneider Director $18.5K May 24, 2021
Francis X. Tirelli Director Jun 30, 2022
Karen Reeves Director Jun 30, 2022
Americo Cicchetti Director Jun 30, 2022
Leonardo Mirandola Cso May 3, 2024
Shannon Ralston 10%+ Owner Jun 3, 2024

Recent Insider Transactions by Companies or Individuals for Kiromic Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.